APA

Ong J. P., Oehler G., Krüger-Jansen C., Lambert-Baumann J. & Younossi Z. M. (20110510). Oral L-ornithine-L-aspartate improves health-related quality of life in cirrhotic patients with hepatic encephalopathy: an open-label, prospective, multicentre observational study. : Clinical drug investigation.

Chicago

Ong Janus P, Oehler Gerd, Krüger-Jansen Christiane, Lambert-Baumann Judith and Younossi Zobair M. 20110510. Oral L-ornithine-L-aspartate improves health-related quality of life in cirrhotic patients with hepatic encephalopathy: an open-label, prospective, multicentre observational study. : Clinical drug investigation.

Harvard

Ong J. P., Oehler G., Krüger-Jansen C., Lambert-Baumann J. and Younossi Z. M. (20110510). Oral L-ornithine-L-aspartate improves health-related quality of life in cirrhotic patients with hepatic encephalopathy: an open-label, prospective, multicentre observational study. : Clinical drug investigation.

MLA

Ong Janus P, Oehler Gerd, Krüger-Jansen Christiane, Lambert-Baumann Judith and Younossi Zobair M. Oral L-ornithine-L-aspartate improves health-related quality of life in cirrhotic patients with hepatic encephalopathy: an open-label, prospective, multicentre observational study. : Clinical drug investigation. 20110510.